Item request has been placed!
×
Item request cannot be made.
×
Processing Request
An Overlooked Cancer Therapy and Clinical-Trial Opportunity.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Subject Terms:
- Abstract:
The article discusses different treatment alternatives for prostate cancer. Topics discussed include an outpatient treatment with minimal side effects and improved recovery "focal therapy," discussed use of "checkpoint inhibitors" like pembrolizumab (Keytruda) and ipilimumab (Yervoy) used against a different malignancies and reported that a trial will be conducted to assess effect of cryo-immune focal therapy and effect of drug "granulocyte-macrophage colony-stimulating factor (GM-CSF)."
No Comments.